ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

UO

University of Oklahoma at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

University of Oklahoma brings 10 presentations to ACR Convergence 2026 in Orlando. Its program centres on bone and joint biology, with work on osteoporosis, pain after joint injury, T cell changes in Sjögren's disease and outpatient CAR T-cell therapy in lupus.

OrganizationACR Convergence 2026 Attendance
UO
University of Oklahoma
Norman, OK
Universities and research institutes
A public research university in Oklahoma.
Session
Sun Nov 8
3:00pm–4:00pm
When Fat Talks to Cartilage: Conversations in the Arthritic Joint
W110A
Osteoarthritis and bone · with Icahn School of Medicine at Mount Sinai
  1. 3:00pmSuper-Stable Lipochondrocytes and CartilageUniversity of California, Irvine
  2. 3:30pmFat and Joint Cross-Talk in OsteoarthritisUniversity of California, San Francisco
Talk
Mon Nov 9
8:30am–9:00am
Part of Curbside Consults
Beyond the Fracture: Understanding Hidden Bone Disease
Hall B, WB3 and WB4
Rare and other diseases
Talk
Mon Nov 9
11:30am–12:30pm
Meet the Professor: Osteoporosis - Enrollment Required
W102B
Osteoarthritis and bone
Session
Mon Nov 9
2:30pm–3:30pm
Check-MAIT: The Interface of the Environment and the Immune System
W204
Immunology · with University of Arizona, Icahn School of Medicine at Mount Sinai
  1. 2:30pmLung Lymphatics in Edema, Inflammation, and ThrombosisWeill Cornell Medicine
  2. 3:00pmCigarettes and MAIT CellsMonash University
Talk
Tue Nov 10
4:00pm–5:00pm
Meet the Professor: Osteoporosis - Enrollment Required
W102B
Osteoarthritis and bone
Session
Wed Nov 11
11:30am–1:00pm
Abstracts: Osteoporosis & Metabolic Bone Disease - Basic & Clinical Science (2953-2958)
W110AB
Osteoarthritis and bone · with Southlake Regional Health Centre
  1. 11:30amReal-World Safety and Efficacy of Romosozumab in Severe Postmenopausal Osteoporosis: A Single-Centre ExperienceSouthern Health and Social Care Trust
  2. 11:45amDenosumab Treatment Significantly Enhances Bone Remodeling and Bone Mineral Density in Rheumatic Diseases Patients with Osteropenia/Osteoporosis:An Prospective Cohort StudyThe First Affiliated Hospital of Xi’an Jiaotong University
  3. 12:00pmThe Osteoporosis Value Paradox: Comparative Cost of Care for Cardiovascular Disease Versus Fragility Fractures and Implications for Secondary PreventionParris and Associates Rheumatology
  4. 12:15pmMultiple Vertebral Fracture as an adverse effect in patients with poor adherence to Denosumab treatment. Retrospective study.Basurto University Hospital
  5. 12:30pmInadequate response to Denosumab: differences between patients with incidental fractures and/or bone loss during treatmentHospital Germans Trias i Pujol
  6. 12:45pmIncident Organ Involvement In FSR-SARC Patient Registry Patients with Self-Reported Bone Sarcoidosis DiagnosisFoundation for Sarcoidosis Research

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Oklahoma

Tell us what you sell and we’ll find the people at University of Oklahoma most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction